Costa Vivian V, Del Sarto Juliana L, Rocha Rebeca F, Silva Flavia R, Doria Juliana G, Olmo Isabella G, Marques Rafael E, Queiroz-Junior Celso M, Foureaux Giselle, Araújo Julia Maria S, Cramer Allysson, Real Ana Luíza C V, Ribeiro Lucas S, Sardi Silvia I, Ferreira Anderson J, Machado Fabiana S, de Oliveira Antônio C, Teixeira Antônio L, Nakaya Helder I, Souza Danielle G, Ribeiro Fabiola M, Teixeira Mauro M
Immunopharmacology Lab, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil.
Host-Interaction Microorganism Lab, Department of Microbiology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
mBio. 2017 Apr 25;8(2):e00350-17. doi: 10.1128/mBio.00350-17.
Zika virus (ZIKV) infection is a global health emergency that causes significant neurodegeneration. Neurodegenerative processes may be exacerbated by -methyl-d-aspartate receptor (NMDAR)-dependent neuronal excitoxicity. Here, we have exploited the hypothesis that ZIKV-induced neurodegeneration can be rescued by blocking NMDA overstimulation with memantine. Our results show that ZIKV actively replicates in primary neurons and that virus replication is directly associated with massive neuronal cell death. Interestingly, treatment with memantine or other NMDAR blockers, including dizocilpine (MK-801), agmatine sulfate, or ifenprodil, prevents neuronal death without interfering with the ability of ZIKV to replicate in these cells. Moreover, experiments demonstrate that therapeutic memantine treatment prevents the increase of intraocular pressure (IOP) induced by infection and massively reduces neurodegeneration and microgliosis in the brain of infected mice. Our results indicate that the blockade of NMDARs by memantine provides potent neuroprotective effects against ZIKV-induced neuronal damage, suggesting it could be a viable treatment for patients at risk for ZIKV infection-induced neurodegeneration. Zika virus (ZIKV) infection is a global health emergency associated with serious neurological complications, including microcephaly and Guillain-Barré syndrome. Infection of experimental animals with ZIKV causes significant neuronal damage and microgliosis. Treatment with drugs that block NMDARs prevented neuronal damage both and These results suggest that overactivation of NMDARs contributes significantly to the neuronal damage induced by ZIKV infection, and this is amenable to inhibition by drug treatment.
寨卡病毒(ZIKV)感染是一种导致严重神经退行性变的全球卫生紧急情况。神经退行性变过程可能会因N-甲基-D-天冬氨酸受体(NMDAR)依赖性神经元兴奋毒性而加剧。在此,我们利用了这样一种假说,即通过美金刚阻断NMDA过度刺激可挽救ZIKV诱导的神经退行性变。我们的结果表明,ZIKV在原代神经元中活跃复制,且病毒复制与大量神经元细胞死亡直接相关。有趣的是,用美金刚或其他NMDAR阻滞剂(包括地卓西平(MK-801)、硫酸胍丁胺或艾芬地尔)进行治疗可预防神经元死亡,而不干扰ZIKV在这些细胞中的复制能力。此外,实验证明,治疗性美金刚治疗可预防感染诱导的眼压(IOP)升高,并大幅减少受感染小鼠大脑中的神经退行性变和小胶质细胞增生。我们的结果表明,美金刚对NMDARs的阻断可提供针对ZIKV诱导的神经元损伤的有效神经保护作用,这表明它可能是对有ZIKV感染诱导神经退行性变风险的患者的一种可行治疗方法。寨卡病毒(ZIKV)感染是一种与严重神经并发症(包括小头畸形和吉兰-巴雷综合征)相关的全球卫生紧急情况。用ZIKV感染实验动物会导致显著的神经元损伤和小胶质细胞增生。用阻断NMDARs的药物进行治疗在[具体情况1]和[具体情况2]中均预防了神经元损伤。这些结果表明,NMDARs的过度激活对ZIKV感染诱导的神经元损伤有显著贡献,并且这可通过药物治疗来抑制。